The Use of Opioids in Neurosurgical Practice: How to be Safe, Effective and Compliant with New Prescribing Laws


Back to Package

This online course provides an update for any neurosurgeon, resident, fellow, nurse practitioner or physician assistant who utilizes opioids in neurosurgical practice. It includes information on the pharmacology and clinical evidence supporting opioids and related medications in neurosurgery patients, how to provide these medications safely to neurosurgical patients – even in those who are chronic opioid users – and how new health care legislation affects the use of opioids in neurosurgical practice.

Pricing

AANS MemberFree
Non-member$49

Faculty

Principal Faculty

  • Christopher J. Winfree, MD, FAANS
  • Joshua M. Rosenow, MD, FAANS
  • Jakun Willard Ing, MD
  • Jason M. Schwalb, MD, FAANS

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the pharmacology and pharmacokinetics of opioids used in neurosurgical practice, including related medications used, such as naloxone and buprenorphine.
  • Recognize the clinical evidence and guidelines for the use of these medications in neurosurgical patients.
  • Apply the perioperative management of neuropathic and nociceptive pain in neurosurgical patients, including in patients who are chronic opioid users.
  • Describe recent opioid legislation and the implications of these new laws on opioid prescribing in neurosurgical practice. 

CME Accreditation

The AANS designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™

Disclaimer

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

Please note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.

Disclosure Information

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Commercial Support, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.

Please find the relevant financial relationships disclosed below for all individuals in control of content. All conflicts of interest have been resolved in accordance with ACCME Standards for Commercial Support.

Name

Relationship/Company

Joshua M. Rosenow, MD, FAANS, FACSConsultant Fees – Boston Scientific Neuromodulation, Voyager therapeutics Other Financial Support – Boston Scientific Neuromodulation
Jason M. Schwalb, MD, FAANS, FACSGrants/Research Support – Stimwave, Medtronic, Guidant, LLC Other Financial Support – Blue Cross Blue Shield of Michigan Consultant Fees – Bluerock Expert Medical Opinion Services Income - Neuros Grants/Research Support – Neuros

Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships to disclose for this activity.

Christopher J. Winfree, MD, FAANS

Jakun Willard Ing, MD

Accreditation

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AANS designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity was published in 5-19-2020. Credit may be obtained until 5-19-2023.

Key:

Complete
Failed
Available
Locked
Christopher J. Winfree, MD, FAANS Video
Open to view video.
Open to view video.
Joshua M. Rosenow, MD, FAANS, FACS Video
Open to view video.
Open to view video.
Jakun Willard Ing, MD Video
Open to view video.
Open to view video.
Jason M. Schwalb, MD, FAANS, FACS Video
Open to view video.
Open to view video.
Evaluation
10 Questions
Quiz
5 Questions  |  2 attempts  |  4/5 points to pass
5 Questions  |  2 attempts  |  4/5 points to pass
Certificate
1.50 AMA PRA Category 1 CreditTM credits  |  Certificate available
1.50 AMA PRA Category 1 CreditTM credits  |  Certificate available